Table 1.
Demographics of the analytical cohort with human milk oligosaccharide profile data
| Control | NEC | P value | |
|---|---|---|---|
|
| |||
| Number of patients | 37 | 33 | – |
| Secretors | 25 (68%) | 20 (61%) | 0.544 |
| Male | 14 (38%) | 22 (67%) | 0.016 |
| Vaginal delivery | 25 (68%) | 17 (52%) | 0.171 |
| Gestational age | 25 (24–26) | 25 (24–27) | 0.881 |
| Birth weight | 670 (585–830) | 670 (600–840) | 1.000 |
| Probiotics ever | 37 (100%) | 31 (94%) | 0.855 |
| MOM only | 3 (8%) | 6 (18%) | 0.468 |
| MOM+formula | 11 (30%) | 12 (37%) | |
| MOM+BMF | 10 (27%) | 7 (21%) | |
| MOM+formula+BMF | 13 (35%) | 8 (24%) | |
| DOL breast milk sample | 18 (12–31) | 18 (13–34) | 0.636 |
| DOL disease onset | – | 19 (14–35) | – |
| NEC surgical | – | 16 | – |
Differences between groups were tested applying χ2 test and Wilcoxon post hoc test where applicable.
BMF, breast milk fortifier; DOL, day of life; MOM, mother’s own breast milk; NEC, necrotising enterocolitis.